Rise in antibiotic-resistant sexually transmitted infections
If you're having unprotected sex with a new or casual partner, get yourself tested for STIs annually even if there are no symptoms. — Freepik
There has been a 'concerning jump' in cases of gonorrhoea resistant to strong antibiotics, health officials have warned.
New figures from the United Kingdom Health Security Agency (UKHSA) show there have been more cases of the sexually transmitted infection (STI) gonorrhoea that are resistant to the antibiotic ceftriaxone so far in 2025 than the whole of last year.
Overall, there was a 16% drop in gonorrhoea cases in 2024 in England, with 71,802 diagnoses, compared with 85,370 in 2023.
However, ceftriaxone-resistant gonorrhoea cases are being detected more frequently – with 14 in the first five months of 2025 compared with 13 in 2024.
Six of the 14 cases this year have been 'extensively drug-resistant,' which means that they were resistant to ceftriaxone and then to second-line treatment options, according to the UKHSA.
Ceftriaxone is a strong antibiotic and the main treatment for gonorrhoea.
Experts are therefore concerned when infections fail to respond to it.
Most of these drug-resistant cases are linked with travel to or from the Asia-Pacific region, where the prevalence of ceftriaxone resistance is high.
Elsewhere, among people in England, early-stage syphilis diagnoses rose 1.7%, from 9,375 in 2023 to 9,535 in 2024.
The overall figure for syphilis, including late-stage syphilis or complications from the infection, increased 5% from 12,456 in 2023 to 13,030 in 2024.
Chlamydia fell 13%, from 194,143 diagnoses in 2023 to 168,889 in 2024, while people diagnosed for the first time with genital warts also dropped.
Among women aged 15 to 24 who are recommended to be screened through the National Chlamydia Screening Programme (NCSP), there was a 10.7% decrease in the number of chlamydia tests carried out, from 673,102 to 601,295.
Dr Hamish Mohammed, consultant epidemiologist at UKHSA, said: 'Levels of STIs in this country remain a big threat to sexual well-being.
'These infections can have a major impact on your health and that of any sexual partners – particularly if they are antibiotic resistant.
'If you've had condomless sex with new or casual partners – either in the UK or overseas – get tested for STIs and HIV at least yearly, even if you don't have symptoms.
'Regular testing protects both you and those you're having sex with.
'From August, eligible people will also be offered vaccination to reduce the risk of gonorrhoea and we expect to see the immunisation programme have an impact on diagnoses of this infection in coming years.'
Professor Matt Phillips, president of the British Association for Sexual Health and HIV, said: 'Whilst it is encouraging to see a fall in the total number of STI diagnoses this year, we nonetheless continue to see historically high rates of sexual infection, with particularly worrying continued increases in infections such as syphilis, which are at their highest-ever levels, and the continued spread of antibiotic-resistant disease.'
It is vital that clear steps are put in place to reverse these trends.
He added: 'Sexual health services remain under immense pressure and these new tools risk being deployed into overstretched systems unable to support them effectively.
'We find ourselves at a critical point for securing the long-term viability of sexual health services in this country.
'Only a joined-up, ambitious national strategy can ensure that we are prepared not just for today's sexual health challenges, but for those we know are coming.' – PA Media/dpa
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
14 hours ago
- The Star
Rise in antibiotic-resistant sexually transmitted infections
If you're having unprotected sex with a new or casual partner, get yourself tested for STIs annually even if there are no symptoms. — Freepik There has been a 'concerning jump' in cases of gonorrhoea resistant to strong antibiotics, health officials have warned. New figures from the United Kingdom Health Security Agency (UKHSA) show there have been more cases of the sexually transmitted infection (STI) gonorrhoea that are resistant to the antibiotic ceftriaxone so far in 2025 than the whole of last year. Overall, there was a 16% drop in gonorrhoea cases in 2024 in England, with 71,802 diagnoses, compared with 85,370 in 2023. However, ceftriaxone-resistant gonorrhoea cases are being detected more frequently – with 14 in the first five months of 2025 compared with 13 in 2024. Six of the 14 cases this year have been 'extensively drug-resistant,' which means that they were resistant to ceftriaxone and then to second-line treatment options, according to the UKHSA. Ceftriaxone is a strong antibiotic and the main treatment for gonorrhoea. Experts are therefore concerned when infections fail to respond to it. Most of these drug-resistant cases are linked with travel to or from the Asia-Pacific region, where the prevalence of ceftriaxone resistance is high. Elsewhere, among people in England, early-stage syphilis diagnoses rose 1.7%, from 9,375 in 2023 to 9,535 in 2024. The overall figure for syphilis, including late-stage syphilis or complications from the infection, increased 5% from 12,456 in 2023 to 13,030 in 2024. Chlamydia fell 13%, from 194,143 diagnoses in 2023 to 168,889 in 2024, while people diagnosed for the first time with genital warts also dropped. Among women aged 15 to 24 who are recommended to be screened through the National Chlamydia Screening Programme (NCSP), there was a 10.7% decrease in the number of chlamydia tests carried out, from 673,102 to 601,295. Dr Hamish Mohammed, consultant epidemiologist at UKHSA, said: 'Levels of STIs in this country remain a big threat to sexual well-being. 'These infections can have a major impact on your health and that of any sexual partners – particularly if they are antibiotic resistant. 'If you've had condomless sex with new or casual partners – either in the UK or overseas – get tested for STIs and HIV at least yearly, even if you don't have symptoms. 'Regular testing protects both you and those you're having sex with. 'From August, eligible people will also be offered vaccination to reduce the risk of gonorrhoea and we expect to see the immunisation programme have an impact on diagnoses of this infection in coming years.' Professor Matt Phillips, president of the British Association for Sexual Health and HIV, said: 'Whilst it is encouraging to see a fall in the total number of STI diagnoses this year, we nonetheless continue to see historically high rates of sexual infection, with particularly worrying continued increases in infections such as syphilis, which are at their highest-ever levels, and the continued spread of antibiotic-resistant disease.' It is vital that clear steps are put in place to reverse these trends. He added: 'Sexual health services remain under immense pressure and these new tools risk being deployed into overstretched systems unable to support them effectively. 'We find ourselves at a critical point for securing the long-term viability of sexual health services in this country. 'Only a joined-up, ambitious national strategy can ensure that we are prepared not just for today's sexual health challenges, but for those we know are coming.' – PA Media/dpa
The Star
2 days ago
- The Star
HIV prevention a priority after 22 cases among varsity students in 2023, 2024
Ling said the cases caused by unsafe sexual practices show a need for more preventive efforts especially among university students. JOHOR recorded 22 Human Immunodeficiency Virus (HIV) cases among university students over the past two years, says state executive councillor Ling Tian Soon. Of this number, 12 cases were recorded last year while 10 were reported in 2023, said the Johor health and environment committee chairman. 'All these cases were found to have been caused by unsafe sexual practices. 'This highlights the need for more preventive efforts among young people, especially university students,' he said during the state assembly sitting. He was responding to a question from Selamat Takim (BN-Sungai Balang) who had asked about the number of HIV cases among university students in Johor, and the efforts to address the issue. Ling said the state government was working with educational institutions to improve HIV awareness among youths via the 'Healthy Without AIDS Programme for Teenagers (Prostar) 2.0'. 'The programme aims to educate teenagers and youths about HIV while also empowering them to be advocates for a healthier lifestyle, free from HIV. 'A total of 1,673 university and secondary school students have taken part in activities held under the programme which began in 2023,' he elaborated. Ling said other initiatives, such as health talks, community forums and awareness campaigns had also been held occasionally to improve understanding of HIV and its prevention. 'Social media and other digital platforms have been used to spread awareness,' he said, adding that the state government was committed to strengthening HIV preventive measures. Health clinics across the state are also providing free and confidential HIV screening for the public, according to Ling. 'This is to encourage early detection for timely intervention. 'The clinics also provide free and confidential counselling services,' he added. — VENESA DEVI
The Sun
2 days ago
- The Sun
Contraceptives for poorest countries stuck in warehouses after US aid cuts
LONDON: Contraceptives that could help prevent millions of unwanted pregnancies in some of the world's poorest countries are stuck in warehouses because of U.S. aid cuts and could be destroyed, two aid industry sources and one former government official said. The stock, held in Belgium and Dubai, includes condoms, contraceptive implants, pills and intrauterine devices, together worth around $11 million, the sources told Reuters. It has been stalled since the Trump administration started cutting foreign aid as part of its 'America First' policy in February, as the U.S. government no longer wants to donate the contraceptives or pay the costs for delivery, they said. The U.S. Agency for International Development (USAID) has instead asked the contractor managing its health supply chain, Chemonics, to try to sell it, two of the sources said. An internal USAID memo, sent in April, said a quantity of contraceptives was being kept in warehouses and they should be 'immediately transferred to another entity to prevent waste or additional costs'. A senior U.S. State Department official told Reuters no decision had been made about the future of the contraceptives. They did not respond to questions about the reasons why the contraceptives were in storage or the impact of the U.S. aid cuts and delays. A spokesperson for Chemonics said they were unable to comment on USAID's plans, but added that the company is working with clients to deliver life-saving aid globally and would continue to support the U.S. government's global health supply chain priorities. The stock represents just under 20% of the supply of contraceptives bought annually by the U.S. for donation overseas, a former USAID official told Reuters. Selling or donating the contraceptives has been challenging, according to the former USAID official, although talks are ongoing. Another option on the table is destroying it, at a cost of several hundred thousand dollars. As time goes on, shelf-lives will also become an issue, one of the sources said. The sources told Reuters that one of the key delays is a lack of response from the U.S. government about what should be done with the stock. It had been destined largely for vulnerable women in sub-Saharan Africa, including young girls who face higher health risks from early pregnancy as well as those fleeing conflict or who otherwise could not afford or access the contraceptives, the sources added. The condoms also help stop the spread of HIV, the former USAID official said. 'We cannot dwell on an issue for too long; when urgency and clarity don't align, we have to move on,' said Karen Hong, chief of UNFPA's supply chain. She said the agency is now working on Plan B to help fill critical supply gaps.
